drugset / Trial / NCT00552175

A Study for the Treatment of Diabetic Peripheral Neuropathic Pain

NCT00552175

Phase 3 Completed 339 enrolled Eli Lilly and Company Shionogi · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.

Timeline

Start
2007-11
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 40 mg Oral
Subject Duloxetine Small molecule 60 mg Oral

Indications